Commission Regulation (EC) No 1050/2009 of 28 October 2009 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, acetamiprid, clomazone, cyflufenamid, emamectin benzoate, famoxadone, fenbutatin oxide, flufenoxuron, fluopicolide, indoxacarb, ioxynil, mepanipyrim, prothioconazole, pyridalyl, thiacloprid and trifloxystrobin in or on certain products, as corrected by OJ L 338, 19.12.2009, p. 105.
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XII Foodstuffs
Joint committee decision (JCD)
042/2010 In force in the EEA
Yes Legal documents
Commission Regulation (EC) No 1050/2009 of 28 October 2009 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, acetamiprid, clomazone, cyflufenamid, emamectin benzoate, famoxadone, fenbutatin oxide, flufenoxuron, fluopicolide, indoxacarb, ioxynil, mepanipyrim, prothioconazole, pyridalyl, thiacloprid and trifloxystrobin in or on certain products, as corrected by OJ L 338, 19.12.2009, p. 105.
Reglugerð framkvæmdastjórnarinnar (EB) nr. 1050/2009 frá 28. október 2009 um breytingu á II. og III. viðauka við reglugerð Evrópuþingsins og ráðsins (EB) nr. 396/2005 að því er varðar hámarksgildi leifa fyrir asoxýstróbín, asetamípríð, klómasón, sýflúfenamíð, emamektínbensóat, famoxadón, fenbútatinoxíð, flúfenoxúrón, flúópíkólíð, indoxakarb, joxýníl, mepanípýrím, próþíókónasól, pýrídalýl, þíaklópríð og trífloxýstróbín í eða á tilteknum afurðum
Verordnung (EG) Nr. 1050/2009 der Kommission vom 28. Oktober 2009 zur Änderung der Anhänge II und III der Verordnung (EG) Nr. 396/2005 des Europäischen Parlaments und des Rates hinsichtlich der Rückstandshöchstgehalte für Azoxystrobin, Acetamiprid, Clomazon, Cyflufenamid, Emamectinbenzoat, Famoxadon, Fenbutatinoxid, Flufenoxuron, Fluopicolid, Indoxacarb, Ioxynil, Mepanipyrim, Prothioconazol, Pyridalyl, Thiacloprid und Trifloxystrobin in oder auf bestimmten Erzeugnissen
Kommisjonsforordning (EF) nr. 1050/2009 av 28. oktober 2009 om endring av vedlegg II og III til europaparlaments- og rådsforordning (EF) nr. 396/2005 med hensyn til grenseverdier for rester av azoksystrobin, acetamiprid, klomazon, cyflufenamid, emamektinbenzoat, famoksadon, fenbutatinoksid, flufenoksuron, fluopikolid, indoksakarb, ioksynil, mepanipyrim, protiokonazol, pyridalyl, tiakloprid og trifloksystrobin i eller på visse produkter
History
01.05.2010
Adopted JCD confirmed entry into force date
01.05.2010
Compliance date in the EEA
30.04.2010
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
16.02.2010
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
28.10.2009
Adoption date in the EU
07.11.2009
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.